The miRNA profiling in PANC-1, PANC-1 GEM 100 and PANC-1 GEM1500 cells
收藏NIAID Data Ecosystem2026-03-10 收录
官方服务：
资源简介：
Gemcitabine has been a first-line therapeutic agent for pancreatic ductal adenocarcinoma (PDAC) pancreatic cancer; however, acquisition of resistance to gemcitabine remains a major challenge. We analyzed miRNAs expression profiles by array-based miRNAs analysis between gemcitabine–resistant (PANC-1/GEM) and parental PANC-1 cells. The three PDAC cells including PANC-1, PANC-1 GEM 100 and PANC-1 GEM1500 were harvested and RNA were isolated. Two independent experiments were performed for each group.
创建时间：
2017-01-01
